Award
National Institute of Allergy and Infectious Diseases 3K23AI182453-02S1
The development & pilot implementation of a Cas13a-based low-cost point-of-care assay for detecting Neisseria gonorrhoeae and molecular markers of antimicrobial resistance in resource-limited settings
Recipient
BRIGHAM AND WOMEN'S HOSPITAL
Awarded
September 18, 2025
Identifier
3K23AI182453-02S1
Award for developing and piloting a low-cost Cas13a-based diagnostic assay for Neisseria gonorrhoeae and antimicrobial resistance markers in resource-limited settings, supporting career development of Dr. Lao-Tzu Allan-Blitz.
Description
This project aims to develop low-cost, point-of-care diagnostic assays for Neisseria gonorrhoeae and antimicrobial resistance markers, leveraging CRISPR technology. The project is funded by NIH and involves collaboration between Brigham and Women's Hospital and other institutions. The award supports career development for Dr. Lao-Tzu Allan-Blitz in assay development and implementation science.